MX2012004877A - Analisis para la deteccion de farmacos anti-tnf y autoanticuerpos. - Google Patents
Analisis para la deteccion de farmacos anti-tnf y autoanticuerpos.Info
- Publication number
- MX2012004877A MX2012004877A MX2012004877A MX2012004877A MX2012004877A MX 2012004877 A MX2012004877 A MX 2012004877A MX 2012004877 A MX2012004877 A MX 2012004877A MX 2012004877 A MX2012004877 A MX 2012004877A MX 2012004877 A MX2012004877 A MX 2012004877A
- Authority
- MX
- Mexico
- Prior art keywords
- autoantibodies
- assays
- detection
- tnf drugs
- drug
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 6
- 229940079593 drug Drugs 0.000 title abstract 4
- 238000003556 assay Methods 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title 1
- BQIMPGFMMOZASS-CLZZGJSISA-N (6r,7r)-7-amino-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(CO)=C(C(O)=O)N2C(=O)[C@@H](N)[C@H]21 BQIMPGFMMOZASS-CLZZGJSISA-N 0.000 abstract 1
- 241000989913 Gunnera petaloidea Species 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rehabilitation Therapy (AREA)
- Physiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25504809P | 2009-10-26 | 2009-10-26 | |
| US26287709P | 2009-11-19 | 2009-11-19 | |
| US32463510P | 2010-04-15 | 2010-04-15 | |
| US34556710P | 2010-05-17 | 2010-05-17 | |
| US35126910P | 2010-06-03 | 2010-06-03 | |
| US38967210P | 2010-10-04 | 2010-10-04 | |
| US39358110P | 2010-10-15 | 2010-10-15 | |
| PCT/US2010/054125 WO2011056590A1 (en) | 2009-10-26 | 2010-10-26 | Assays for the detection of anti-tnf drugs and autoantibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012004877A true MX2012004877A (es) | 2012-05-23 |
Family
ID=43618083
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012004877A MX2012004877A (es) | 2009-10-26 | 2010-10-26 | Analisis para la deteccion de farmacos anti-tnf y autoanticuerpos. |
| MX2014002586A MX343328B (es) | 2009-10-26 | 2010-10-26 | Analisis para la deteccion de farmacos anti-tnf y anticuerpos. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014002586A MX343328B (es) | 2009-10-26 | 2010-10-26 | Analisis para la deteccion de farmacos anti-tnf y anticuerpos. |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US8574855B2 (https=) |
| EP (1) | EP2494352B1 (https=) |
| JP (3) | JP5697677B2 (https=) |
| KR (2) | KR101881714B1 (https=) |
| CN (2) | CN102695955B (https=) |
| AU (4) | AU2010315547C1 (https=) |
| BR (1) | BR112012009855A2 (https=) |
| CA (2) | CA2778454C (https=) |
| ES (1) | ES2796530T3 (https=) |
| IL (2) | IL219315B (https=) |
| MX (2) | MX2012004877A (https=) |
| NZ (3) | NZ706187A (https=) |
| RU (2) | RU2015148676A (https=) |
| WO (1) | WO2011056590A1 (https=) |
| ZA (2) | ZA201203717B (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3225625A1 (en) | 2002-09-11 | 2017-10-04 | Chugai Seiyaku Kabushiki Kaisha | Protein purification method |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| JP5697677B2 (ja) | 2009-10-26 | 2015-04-08 | ネステク ソシエテ アノニム | 抗ｔｎｆ薬及び自己抗体の検出用アッセイ |
| NZ609363A (en) | 2010-10-18 | 2015-04-24 | Nestec Sa | Methods for determining anti-drug antibody isotypes |
| CA2827609A1 (en) * | 2011-02-17 | 2012-11-15 | Nestec S.A. | Assays for detecting autoantibodies to anti-tnf.alpha. drugs |
| AU2012253422B2 (en) | 2011-05-10 | 2015-08-13 | Société des Produits Nestlé S.A. | Methods of disease activity profiling for personalized therapy management |
| KR20140047628A (ko) * | 2011-07-06 | 2014-04-22 | 네스텍 소시에테아노님 | Ｔｎｆ알파로의 생물학적 치료요법에 대한 중화 자가항체의 검출을 위한 검정 |
| EP2786156A2 (en) * | 2011-11-30 | 2014-10-08 | AbbVie Deutschland GmbH & Co KG | Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor |
| KR102084805B1 (ko) * | 2012-03-08 | 2020-03-04 | 에프. 호프만-라 로슈 아게 | 순환 면역 복합체의 특성화를 위한 다중 크로마토그래피-면역분석 방법 |
| US20130295685A1 (en) * | 2012-04-10 | 2013-11-07 | Nestec S.A. | Mobility shift assays for detecting anti-tnf alpha drugs and autoantibodies |
| US10132736B2 (en) | 2012-05-24 | 2018-11-20 | Abbvie Inc. | Methods for inspection of protein particles in a liquid beneficial agent |
| WO2014046474A2 (ko) * | 2012-09-21 | 2014-03-27 | 가톨릭대학교 산학협력단 | 메트포민을 유효성분으로 함유하는 염증성 장질환의 예방 또는 치료용 조성물 |
| KR101501375B1 (ko) | 2012-09-21 | 2015-03-10 | 가톨릭대학교 산학협력단 | 메트포민을 유효성분으로 함유하는 염증성 장질환의 예방 또는 치료용 조성물 |
| EP2904405B1 (en) | 2012-10-05 | 2017-05-31 | Nestec S.A. | Methods for predicting and monitoring mucosal healing |
| BR112015012482A2 (pt) * | 2012-11-30 | 2017-07-11 | Nestec Sa | ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicos |
| WO2014122600A1 (en) | 2013-02-05 | 2014-08-14 | Nestec S.A. | Methods of selecting combination therapy for colorectal cancer patients |
| WO2014184768A1 (en) * | 2013-05-16 | 2014-11-20 | University Of Pretoria | A method of diagnosing tuberculosis |
| WO2015083087A1 (en) | 2013-12-03 | 2015-06-11 | Nestec S.A. | Methods for predicting post-operative recurrence of crohn's disease |
| CA2932569A1 (en) | 2013-12-03 | 2015-06-11 | Societe Des Produits Nestle S.A. | Signaling pathways in tissues from inflammatory bowel disease patients |
| WO2015110989A1 (en) | 2014-01-23 | 2015-07-30 | Nestec S.A. | Biomarker panel for assessment of mucosal healing |
| WO2015166461A1 (en) | 2014-05-01 | 2015-11-05 | Nestec S.A. | Methods of selecting treatment regimen using tnf alpha and anti-tnf alpha drug levels |
| MX2017004816A (es) | 2014-10-20 | 2017-08-02 | Nestec Sa | Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa. |
| CA2964857A1 (en) | 2014-10-20 | 2016-04-28 | Nestec S.A. | Methods for prediction of anti-tnf alpha drug levels and autoantibody formation |
| HK1244881A1 (zh) | 2014-12-02 | 2018-08-17 | Société des Produits Nestlé S.A. | 建立维多珠单坑给药方案以治疗患有易激惹肠病的患者的方法 |
| CN107250798A (zh) | 2014-12-05 | 2017-10-13 | 雀巢产品技术援助有限公司 | 用于检测患者样品中的生物制品的间接均相迁移率变动试验 |
| CN107110853A (zh) * | 2015-01-09 | 2017-08-29 | 阿通诺米斯公司 | 确定TNFα抑制药及其相应抗药抗体的量的通用测定法 |
| WO2016135707A1 (en) | 2015-02-27 | 2016-09-01 | Nestec S.A. | Diagnosis of major depressive disorder, mild cognitive impairment, and alzheimer's disease and other neurologic and psychiatric disorders |
| ES2716900T3 (es) | 2015-11-06 | 2019-06-17 | Promise Advanced Proteomics | Un método para cuantificar anticuerpos anti-TNF |
| EP3165922B1 (en) | 2015-11-06 | 2020-06-17 | Promise Proteomics | A method for quantifying therapeutic antibodies |
| WO2017201142A1 (en) * | 2016-05-17 | 2017-11-23 | Memorial Sloan Kettering Cancer Center | Treatment of lung adenocarcinoma |
| WO2018007327A1 (en) * | 2016-07-08 | 2018-01-11 | Atonomics A/S | A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples |
| KR20200069333A (ko) | 2017-10-10 | 2020-06-16 | 프로메테우스 바이오사이언시즈, 인크. | 베돌리주맙 치료를 모니터링하는 방법 |
| EP3514541A1 (de) * | 2018-01-17 | 2019-07-24 | Siemens Healthcare Diagnostics Products GmbH | Verfahren zur quantitativen bestimmung eines therapeutischen tnf-alpha inhibitors |
| EP3781941B1 (en) * | 2018-04-20 | 2026-01-14 | Janssen Biotech, Inc. | Chromatography column qualification in manufacturing methods for producing anti-tnf antibody compositions |
| WO2020112890A1 (en) | 2018-11-29 | 2020-06-04 | Cedars-Sinai Medical Center | Rnaset2 compositions and methods of treatment therewith |
| US20230035363A1 (en) * | 2019-03-04 | 2023-02-02 | Amgen Inc. | In vivo reversibility of high molecular weight species |
| KR102562006B1 (ko) | 2020-11-09 | 2023-08-02 | 바디텍메드(주) | 항tnf-알파 약물 모니터링을 위한 신속 검출 키트 |
| WO2024249568A1 (en) | 2023-05-30 | 2024-12-05 | Paragon Therapeutics, Inc. | Alpha4beta7 integrin antibody compositions and methods of use |
| CN121889424A (zh) | 2023-08-14 | 2026-04-17 | 派拉冈医疗公司 | α4β7整联蛋白结合蛋白及使用方法 |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5700466A (en) | 1981-09-08 | 1997-12-23 | The Rockefeller University | Method of ameliorating or preventing septic shock using a monoclonal antibody specific to cachectin/tumor necrosis factor |
| US4459359A (en) | 1981-11-19 | 1984-07-10 | New York Blood Center, Inc. | Sensitive immunoassays of antigens or antibodies sequestered within immune complexes |
| US5672347A (en) | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
| US4857456A (en) | 1985-04-30 | 1989-08-15 | The Regents Of The University Of California | Assay of Bone morphogenetic protein (BMP) and anti-BMP antibody for the diagnosis of bone disorders |
| FR2590674B1 (fr) | 1985-11-25 | 1989-03-03 | Inst Nat Sante Rech Med | Nouveaux reactifs de diagnostic |
| DE3631229A1 (de) | 1986-09-13 | 1988-03-24 | Basf Ag | Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung |
| US5223395A (en) | 1988-12-01 | 1993-06-29 | Centocor, Inc. | Immunometric assays for tumor necrosis factor-alpha and methods for preventing the loss of biological activity of tumor necrosis factor-alpha in biological samples |
| EP0440044A1 (en) | 1990-01-31 | 1991-08-07 | Abbott Laboratories | Avoidance of human anti-mouse antibody interference in in vitro diagnostic testing |
| US5094740A (en) | 1990-02-16 | 1992-03-10 | Glycomed, Inc. | Two-dimensional electrophoretic separation of carbohydrates |
| GB9028123D0 (en) * | 1990-12-28 | 1991-02-13 | Erba Carlo Spa | Monoclonal antibodies against human tumor necrosis factor alpha |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5582998A (en) | 1991-06-19 | 1996-12-10 | Boehringer Ingelheim International Gmbh | Monoclonal antibodies against human TNF-binding protein I (TNF-BP I) and immunoassays therefor |
| JPH0566222A (ja) | 1991-09-09 | 1993-03-19 | Tosoh Corp | 物質の分析方法 |
| ES2156149T3 (es) | 1992-12-04 | 2001-06-16 | Medical Res Council | Proteinas de union multivalente y multiespecificas, su fabricacion y su uso. |
| DE69426223T2 (de) | 1993-09-07 | 2001-05-23 | Wako Pure Chemical Industries, Ltd. | Verfahren und Reagenz zur Messung der Komplementaktivität |
| JPH07110331A (ja) * | 1993-09-07 | 1995-04-25 | Wako Pure Chem Ind Ltd | ヒト補体価測定方法及びヒト補体価測定用試薬組成物 |
| JPH07140144A (ja) | 1993-11-19 | 1995-06-02 | S R L:Kk | アレルゲン特異的ＩｇＥ抗体の測定方法および抗原抗体複合体の測定方法 |
| EP0796280B1 (en) * | 1994-12-28 | 2003-03-26 | University Of Kentucky | Murine monoclonal anti-idiotype antibody 3h1 |
| MX336813B (es) * | 1996-02-09 | 2016-02-02 | Abbvie Biotechnology Ltd | Anticuerpos humanos que ligan el tnfa humano. |
| AU727500B2 (en) | 1996-08-12 | 2000-12-14 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Container for measurement of cell functions, kit for measurement of cell functions and method for measuring cell functions |
| JP3718435B2 (ja) * | 1996-08-12 | 2005-11-24 | 積水化学工業株式会社 | 細胞機能測定用容器及び細胞機能測定方法 |
| US6391622B1 (en) | 1997-04-04 | 2002-05-21 | Caliper Technologies Corp. | Closed-loop biochemical analyzers |
| US6309888B1 (en) | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
| CA2348698C (en) * | 1998-10-31 | 2012-01-03 | Syed V. S. Kashmiri | Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| US6818749B1 (en) * | 1998-10-31 | 2004-11-16 | The United States Of America As Represented By The Department Of Health And Human Services | Variants of humanized anti carcinoma monoclonal antibody cc49 |
| DE19858777B4 (de) * | 1998-12-18 | 2006-07-27 | Delta Biotechnology Ltd. | Verfahren zur teilweisen oder vollständigen Trennung von glykosilierten und nicht-glykosilierten Proteinen |
| ATE362912T1 (de) * | 1999-12-06 | 2007-06-15 | Leo Pharma As | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha |
| US6680209B1 (en) | 1999-12-06 | 2004-01-20 | Biosite, Incorporated | Human antibodies as diagnostic reagents |
| WO2001044472A1 (en) | 1999-12-16 | 2001-06-21 | Amgen, Inc. | Tnfr/opg-like molecules and uses thereof |
| UA81743C2 (uk) * | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
| EP1370867B1 (en) | 2001-03-02 | 2010-08-04 | Activx Biosciences, Inc. | Protein profiling platform |
| US7256257B2 (en) * | 2001-04-30 | 2007-08-14 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| WO2003016909A1 (en) | 2001-08-16 | 2003-02-27 | Ludwig Institute For Cancer Research | Method for determining protein component in a biological sample |
| ATE469176T1 (de) | 2001-11-12 | 2010-06-15 | Merck Patent Gmbh | Modifizierter anti-tnf antikörper |
| US20060110407A1 (en) | 2001-12-05 | 2006-05-25 | Shelley Stopera | Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection |
| GB0208817D0 (en) | 2002-04-17 | 2002-05-29 | European Molecular Biology Lab Embl | Method for producing monoclonal antibodies |
| US20040022792A1 (en) | 2002-06-17 | 2004-02-05 | Ralph Klinke | Method of stabilizing proteins at low pH |
| US20060078944A1 (en) | 2002-08-01 | 2006-04-13 | Jun Kuai | Methods and reagents relating to inflammation and apoptosis |
| US20060034845A1 (en) | 2002-11-08 | 2006-02-16 | Karen Silence | Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
| US7662569B2 (en) | 2003-04-11 | 2010-02-16 | Cedars-Sinai Medical Center | Methods of assessing Crohn's disease patient phenotype by I2 serologic response |
| US8088387B2 (en) * | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| JP4717810B2 (ja) | 2003-06-20 | 2011-07-06 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション インコーポレイテッド | １型糖尿病と２型糖尿病を識別するためのバイオマーカー |
| BRPI0413197A (pt) * | 2003-08-01 | 2006-10-03 | Amgen Inc | cristal de eta wercept; método para fabricar um cristal de etanercept; composição; uso de um cristal de etanercept |
| JP2007528868A (ja) | 2003-08-14 | 2007-10-18 | ワイス | 抗ルイスｙ抗イディオタイプ抗体およびその使用 |
| EP1519194A1 (en) | 2003-09-24 | 2005-03-30 | Roche Diagnostics GmbH | Use of gfap for identification of intracerebral hemorrhage |
| US20090275496A1 (en) | 2004-05-07 | 2009-11-05 | Peptimmune, Inc. | Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods |
| US20060003384A1 (en) | 2004-06-30 | 2006-01-05 | Wagner Carrie L | Detection of measurement of antibodies to antigenic proteins in biological tissues or samples |
| US20060253263A1 (en) | 2005-04-11 | 2006-11-09 | Meshkin Brian J | Method to optimize drug selection, dosing and evaluation and to help predict therapeutic response and toxicity from immunosuppressant therapy |
| ZA200709956B (en) | 2005-05-20 | 2009-02-25 | Genentech Inc | Pretreatment of a biological sample from an autoimmune disease subject |
| GB2426581A (en) * | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
| WO2007009469A2 (en) | 2005-07-21 | 2007-01-25 | Genmab A/S | Potency assays for antibody drug substance binding to an fc receptor |
| US20090162374A1 (en) | 2005-09-14 | 2009-06-25 | Geraghty Daniel E | Specific removal of activated immune cells |
| US7542502B2 (en) | 2005-09-27 | 2009-06-02 | Cymer, Inc. | Thermal-expansion tolerant, preionizer electrode for a gas discharge laser |
| AU2006311475A1 (en) * | 2005-11-08 | 2007-05-18 | Medarex, Inc. | TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy |
| JP2007147367A (ja) | 2005-11-25 | 2007-06-14 | Sekisui Chem Co Ltd | サイトカイン産生能の測定方法 |
| DE102005057920A1 (de) | 2005-12-02 | 2007-06-28 | Strohner, Pavel, Dr. | Immunoassay zur simultanen immunchemischen Bestimmung eines Analyten (Antigen) und eines gegen den Analyten gerichteten Therapieantikörpers in Proben |
| US20100130367A1 (en) | 2006-07-11 | 2010-05-27 | Drexel University | Methods of Quantitatively Assessing Inflammation with Biosensing Nanoparticles |
| US20080286774A1 (en) | 2007-05-16 | 2008-11-20 | The Regents Of The University Of California | Real-time individualized therapy evaluation |
| US20090035216A1 (en) | 2007-08-03 | 2009-02-05 | Biomonitor Aps | Method for determining in vivo biopharmaceutical concentration or bioavailability |
| EP2200613B1 (en) * | 2007-09-21 | 2018-09-05 | The Johns Hopkins University | Phenazine derivatives and uses thereof |
| WO2009091240A1 (en) | 2008-01-15 | 2009-07-23 | Stichting Sanquin Bloedvoorziening | Method and kits for detecting antibodies against therapeutic antibodies |
| CA2716522A1 (en) | 2008-03-05 | 2009-10-15 | Singulex, Inc. | Methods and compositions for highly sensitive detection of molecules |
| JP5697677B2 (ja) | 2009-10-26 | 2015-04-08 | ネステク ソシエテ アノニム | 抗ｔｎｆ薬及び自己抗体の検出用アッセイ |
| NZ609363A (en) | 2010-10-18 | 2015-04-24 | Nestec Sa | Methods for determining anti-drug antibody isotypes |
| CA2827609A1 (en) | 2011-02-17 | 2012-11-15 | Nestec S.A. | Assays for detecting autoantibodies to anti-tnf.alpha. drugs |
| US20130266963A1 (en) | 2011-07-06 | 2013-10-10 | Nestec S.A. | Assay for detecting neutralizing autoantibodies to biologic therapy |
| KR20140047628A (ko) | 2011-07-06 | 2014-04-22 | 네스텍 소시에테아노님 | Ｔｎｆ알파로의 생물학적 치료요법에 대한 중화 자가항체의 검출을 위한 검정 |
| US20140051184A1 (en) | 2012-08-15 | 2014-02-20 | Nestec S.A. | Mobility shift assays for detecting anti-tnf alpha drugs and autoantibodies thereto |
| US20130295685A1 (en) | 2012-04-10 | 2013-11-07 | Nestec S.A. | Mobility shift assays for detecting anti-tnf alpha drugs and autoantibodies |
| BR112015012482A2 (pt) | 2012-11-30 | 2017-07-11 | Nestec Sa | ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicos |
| CN107250798A (zh) | 2014-12-05 | 2017-10-13 | 雀巢产品技术援助有限公司 | 用于检测患者样品中的生物制品的间接均相迁移率变动试验 |
-
2010
- 2010-10-26 JP JP2012536962A patent/JP5697677B2/ja not_active Expired - Fee Related
- 2010-10-26 NZ NZ706187A patent/NZ706187A/en not_active IP Right Cessation
- 2010-10-26 EP EP10778763.2A patent/EP2494352B1/en active Active
- 2010-10-26 RU RU2015148676A patent/RU2015148676A/ru not_active Application Discontinuation
- 2010-10-26 MX MX2012004877A patent/MX2012004877A/es active IP Right Grant
- 2010-10-26 CN CN201080060442.5A patent/CN102695955B/zh not_active Expired - Fee Related
- 2010-10-26 CA CA2778454A patent/CA2778454C/en active Active
- 2010-10-26 ES ES10778763T patent/ES2796530T3/es active Active
- 2010-10-26 MX MX2014002586A patent/MX343328B/es unknown
- 2010-10-26 NZ NZ621655A patent/NZ621655A/en not_active IP Right Cessation
- 2010-10-26 BR BR112012009855A patent/BR112012009855A2/pt not_active Application Discontinuation
- 2010-10-26 WO PCT/US2010/054125 patent/WO2011056590A1/en not_active Ceased
- 2010-10-26 NZ NZ599456A patent/NZ599456A/en not_active IP Right Cessation
- 2010-10-26 KR KR1020177020281A patent/KR101881714B1/ko not_active Expired - Fee Related
- 2010-10-26 CA CA3108458A patent/CA3108458A1/en active Pending
- 2010-10-26 KR KR1020127013748A patent/KR101761541B1/ko not_active Expired - Fee Related
- 2010-10-26 CN CN201510067719.1A patent/CN104634955B/zh not_active Expired - Fee Related
- 2010-10-26 RU RU2012121710/15A patent/RU2571489C2/ru not_active IP Right Cessation
- 2010-10-26 AU AU2010315547A patent/AU2010315547C1/en not_active Ceased
-
2012
- 2012-04-06 US US13/441,727 patent/US8574855B2/en active Active
- 2012-04-19 IL IL219315A patent/IL219315B/en not_active IP Right Cessation
- 2012-05-22 ZA ZA2012/03717A patent/ZA201203717B/en unknown
-
2013
- 2013-10-04 US US14/046,863 patent/US8865417B2/en active Active
-
2014
- 2014-07-21 US US14/336,955 patent/US9506920B2/en active Active
-
2015
- 2015-02-10 JP JP2015024359A patent/JP5878253B2/ja not_active Expired - Fee Related
- 2015-05-28 AU AU2015202899A patent/AU2015202899B2/en not_active Ceased
- 2015-06-23 ZA ZA201504548A patent/ZA201504548B/en unknown
-
2016
- 2016-01-26 JP JP2016012688A patent/JP6082831B2/ja not_active Expired - Fee Related
- 2016-10-19 US US15/297,878 patent/US10386366B2/en active Active
-
2017
- 2017-08-14 AU AU2017213584A patent/AU2017213584B2/en not_active Ceased
-
2018
- 2018-01-04 IL IL256728A patent/IL256728A/en unknown
-
2019
- 2019-07-02 US US16/460,597 patent/US20200018751A1/en not_active Abandoned
- 2019-07-12 AU AU2019205009A patent/AU2019205009A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012004877A (es) | Analisis para la deteccion de farmacos anti-tnf y autoanticuerpos. | |
| MX343327B (es) | Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa. | |
| WO2013030578A3 (en) | Method for detecting nucleosomes | |
| EP3264090A3 (en) | Method for detecting nucleosome adducts | |
| SG10201408392PA (en) | Methods of determining patient response by measurement of her-3 | |
| CO6680668A2 (es) | Ensayos biomarcadores para detectar o medir inhibición de actividad quinasa tor | |
| MX357550B (es) | Microarn plasmaticos para la deteccion de cancer colorrectal temprano. | |
| ATE472110T1 (de) | Sensoreinrichtung und verfahren zur erfassung von magnetischen teilchen | |
| FR2969916B1 (fr) | Systeme et procede pour detecter la sensibilite d'une personne a une ou plusieurs substances possiblement allergisantes | |
| EP2596132A4 (en) | METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS | |
| FR2996673B1 (fr) | Capteur capacitif pour la detection de presence d'un objet et/ou d'un individu. | |
| PH12013500544A1 (en) | Breast cancer diagnostics | |
| WO2013009703A8 (en) | Antibodies, kit and method for detecting amyloid beta oligomers | |
| MX2013013986A (es) | Deteccion rapida de actividad metabolica. | |
| MX2015006852A (es) | Ensayos para detectar autoanticuerpos neutralizantes para terapia biologica. | |
| WO2010136163A8 (en) | Secernin-1 as a marker for cancer | |
| MX2013007789A (es) | Dispositivo de escaneo de codigo de barras que determina la cantidad fisiologica del paciente. | |
| FR2953292B1 (fr) | Capteur d'hydrogene et procede de detection d'une concentration en hydrogene. | |
| EP2573192A4 (en) | METHOD AND KIT FOR DIAGNOSIS OF AIM-MEDIATED ILLNESSES | |
| MX2012009908A (es) | Ensayos y equipos para la serotipificacion de pseudomas aeruginosa y secuencias de oligonucleotido utiles en dichos metodos y equipos. | |
| TN2015000161A1 (en) | Methylglyoxal as a marker of cancer | |
| EP4386381A3 (en) | Sensor for detection of gas and method for detection of gas | |
| BRPI1009573A2 (pt) | método para avaliar uma condição artrítica em um sujeito, kit para detectar a presença de um auto-anticorpo, e, método para determinar o subtipo de artrite em um paciente. | |
| WO2011085057A3 (en) | Methods for detecting insulin autoantibody | |
| GB2470757B (en) | Non invasive gas analysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: NESTEC S.A. |
|
| FG | Grant or registration |